Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Know Labs, Inc.

< Previous 1 2 Next >
Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs’ Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Furthers External Validation of Bio-RFID™ Technology with Study Published in Sensors Journal
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Reports Second Quarter FY2023 Results
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2023 Results on May 15, 2023
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Study Validates Technical Feasibility of its Novel Sensor for Non-Invasive Glucose Monitoring
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Forms New Scientific Advisory Board, Appoints Respected Researchers in Medical Innovation as First Members
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Reports First Quarter 2023 Results
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2023 Results on February 14, 2023
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Names Ron Erickson Chief Executive Officer; Former CEO Phil Bosua Becomes a Technology Consultant to the Company
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Expands IP Leadership in Non-Invasive Diagnostics with New High Performance Glucose Sensor Patent
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2022 Results
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Addresses False and Incomplete Short Seller’s Claims
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. to Host Review of Fiscal Year 2022 Results on December 20, 2022
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs Participating in Second Annual Bernstein CGM Disruptors Conference
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common Stock
From Know Labs, Inc.
Via Business Wire
Tickers KNW
Know Labs, Inc. Announces Pricing of Upsized $7.2 Million Public Offering of Common Stock and Uplisting to the NYSE American Exchange
From Know Labs, Inc.
Via Business Wire
Know Labs, Inc. Announces NYSE American Listing Approval
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA Clearance Application
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFID™ Non-Invasive Diagnostic Technology
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2M in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
New Test Data Confirm Particle™ Bulb from Know Labs Successfully Inactivates SARS-CoV-2 Variants
From Know Labs, Inc.
Via Business Wire
Tickers KNWN
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.